13F Filings History of Gilead Therapeutics A1 Unlimited Co

Latest 13F report
Q4 2025 - 12 Feb 2026
Location
Co Cork, Ireland
Summary
This page shows a list of all the recent 13F filings made by Gilead Therapeutics A1 Unlimited Co. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GILEAD SCIENCES, INC. is reporting for Gilead Therapeutics A1 Unlimited Co.

Notify me when Gilead Therapeutics A1 Unlimited Co files a new 13F portfolio report.

⭐ Subscribe ⭐

GILEAD SCIENCES, INC. is reporting for Gilead Therapeutics A1 Unlimited Co:

Name Holdings Value Location File Number
GILEAD SCIENCES, INC. $1,935,507,854 Foster City, CA 028-25078